Haemonetics Corporation
Could not find a ticker for this position, may be a filing error
A maker of medical devices and software for collecting, processing, and managing blood and plasma, Haemonetics builds the machines and disposable kits used by blood banks, hospitals, and plasma centers — including its NexSys plasma collection systems and apheresis devices that pull out specific components like platelets. The company was founded in 1971 by Dr. Allen "Jack" Latham, Jr., who invented the "Latham Bowl," a transparent disposable centrifuge bowl that automated blood separation. Its name blends "haemo," the Greek word for blood, with "-netics," a nod to genetics and cybernetics.
2.5% Convertible Senior Notes due 2029
Granted 1.17M · Bought 60.0K · Sold 219.0K
Granted 460.2K · Bought 2.0K · Sold 348.4K
Granted 226.5K · Sold 127.4K
Granted 284.4K · Bought 3.8K · Sold 270.8K
Granted 263.8K · Bought 3.1K · Sold 221.5K
Granted 68.0K
Granted 167.8K · Bought 4.4K · Sold 120.5K
Granted 24.0K · Bought 1.4K · Sold 1.0K
Granted 40.2K · Sold 604
Granted 77.7K · Sold 49.2K
Granted 50.3K · Sold 12.2K
Granted 26.2K · Bought 3.9K · Sold 7.8K
Granted 153.7K · Sold 137.6K
Granted 41.7K · Sold 22.4K
Granted 21.0K · Bought 4.0K
Granted 123.4K · Bought 1.4K · Sold 99.1K
Granted 15.9K · Sold 535
Granted 117.6K · Bought 1.0K · Sold 101.5K
Granted 39.2K · Sold 11.0K
Granted 80.9K · Bought 2.4K · Sold 71.9K
Granted 19.7K
Granted 20.2K
Granted 29.1K
Granted 41.7K · Sold 18.6K
Granted 100.1K · Bought 3.0K · Sold 90.5K
Granted 91.6K · Bought 4.4K · Sold 85.5K
Granted 16.6K · Sold 557
Granted 16.9K
Granted 16.2K
Granted 12.1K · Sold 249
Granted 56.8K · Bought 1.9K · Sold 55.6K
Granted 15.4K
Granted 112.4K · Bought 5.3K · Sold 119.6K
Granted 27.2K · Sold 13.2K
Sold 1.1K
Granted 80.4K · Sold 74.0K
Granted 10.5K · Bought 416
Granted 12.9K
Granted 12.5K · Sold 12.5K
Granted 54.4K · Bought 685 · Sold 48.7K
Granted 40.7K
Bought 411
Granted 605.6K · Sold 600.0K
Granted 61.2K · Bought 200.0K · Sold 253.2K
Granted 5.3K
Granted 8.0K · Sold 8.0K
Granted 15.6K · Sold 11.8K
Granted 7.1K
Granted 6.9K
Granted 33.2K
Granted 5.7K · Sold 406
Granted 41.8K · Bought 1.5K · Sold 41.0K
Granted 33.0K · Sold 31.0K
Granted 34.9K · Sold 36.5K
Granted 20.0K · Bought 2.9K · Sold 20.0K
Bought 440
Granted 2.8K · Bought 209
Granted 400 · Bought 238 · Sold 623
Granted 1.0K · Bought 231 · Sold 1.0K
Granted 184.1K · Bought 2.4K · Sold 205.8K
Granted 206.2K · Bought 331 · Sold 206.2K
Bought 422
Granted 3.0K · Sold 1.1K
Bought 304
Granted 17.0K · Bought 159 · Sold 15.0K
Granted 21.9K · Sold 21.0K
Bought 126
Bought 215
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Simon, ChristopherPresident & CEO, Director · 58 transactions | — | 444.7K | 1.17M | 60.0K | 219.0K |
| Concannon BrianPresident & CEO, Director · 204 transactions | — | 147.0Kas of Sep 2015 | 460.2K | 2.0K | 348.4K |
| Basil Michelle LEVP and General Counsel · 75 transactions | — | 68.8K | 226.5K | — | 127.4K |
| Allen Peter MPresident, Global Plasma · 87 transactions | — | 64.6Kas of Jul 2015 | 284.4K | 3.8K | 270.8K |
| Lindop Christopher JCFO & EVP Business Development · 72 transactions | — | 56.7Kas of Jan 2016 | 263.8K | 3.1K | 221.5K |
| DArecca JamesEVP, Chief Financial Officer · 18 transactions | — | 54.4K | 68.0K | — | — |
| Gelbman Ronald GDirector · 70 transactions | — | 48.4Kas of Nov 2019 | 167.8K | 4.4K | 120.5K |
| Jesse SandraEVP and Chief Legal Officer · 14 transactions | — | 48.2Kas of Oct 2016 | 24.0K | 1.4K | 1.0K |
| Miller Laurie A.SVP, Human Resources · 31 transactions | — | 41.0K | 40.2K | — | 604 |
| Meelia Richard JDirector · 23 transactions | — | 32.0Kas of Feb 2021 | 77.7K | — | 49.2K |
| Llorens JosepEVP, Global Manufacturing · 33 transactions | — | 30.9Kas of May 2024 | 50.3K | — | 12.2K |
| White JonathanChief Science and Technology · 38 transactions | — | 30.5Kas of Oct 2015 | 26.2K | 3.9K | 7.8K |
| Burke William P. Mr.EVP, Chief Financial Officer · 48 transactions | — | 30.3Kas of Aug 2021 | 153.7K | — | 137.6K |
| Dockendorff Charles JDirector · 14 transactions | — | 25.0Kas of Jul 2025 | 41.7K | — | 22.4K |
| Abernathy Robert EDirector · 10 transactions | — | 25.0Kas of Jul 2025 | 21.0K | 4.0K | — |
| Kroll Mark WDirector · 67 transactions | — | 24.8K | 123.4K | 1.4K | 99.1K |
| Selman ByronPresident, Global Markets · 5 transactions | — | 23.3Kas of Oct 2016 | 15.9K | — | 535 |
| Foote Susan BartlettDirector · 67 transactions | — | 21.5Kas of Nov 2017 | 117.6K | 1.0K | 101.5K |
| Lingamneni AnilaEVP, Chief Technology Officer · 25 transactions | — | 21.3Kas of Jul 2024 | 39.2K | — | 11.0K |
| Hanlon Susan MVP Finance · 78 transactions | — | 20.5Kas of Oct 2015 | 80.9K | 2.4K | 71.9K |
| Ryding Neil 122-62-507EVP, Global Manufacturing · 4 transactions | — | 19.7Kas of Jun 2017 | 19.7K | — | — |
| Burzik Catherine MDirector · 7 transactions | — | 19.5Kas of Aug 2022 | 20.2K | — | — |
| Zane Ellen MDirector · 13 transactions | — | 19.4Kas of Jul 2025 | 29.1K | — | — |
| Strong Stewart WPresident, Global Hospital · 29 transactions | — | 18.2Kas of Jul 2024 | 41.7K | — | 18.6K |
| Merriman RonaldDirector · 49 transactions | — | 17.8Kas of May 2017 | 100.1K | 3.0K | 90.5K |
| Forish Joseph JVP, Human Resources · 45 transactions | — | 17.3Kas of Apr 2013 | 91.6K | 4.4K | 85.5K |
| Davies Kent JChief Operating Officer · 5 transactions | — | 16.9Kas of Oct 2015 | 16.6K | — | 557 |
| Pomeroy ClaireDirector · 8 transactions | — | 16.9Kas of Jul 2025 | 16.9K | — | — |
| Fusco DavidEVP, Global Human Resources · 4 transactions | — | 16.9Kas of Oct 2016 | 16.2K | — | — |
| Burns Brian REVP, Global QA/RA · 5 transactions | — | 16.2Kas of Oct 2015 | 12.1K | — | 249 |
| Ebbeling Robert BVice President, Operations · 19 transactions | — | 15.8Kas of May 2009 | 56.8K | 1.9K | 55.6K |
| Coyle Michael JDirector · 7 transactions | — | 15.4Kas of Jul 2025 | 15.4K | — | — |
| Granadillo Pedro PDirector · 73 transactions | — | 15.3Kas of Nov 2018 | 112.4K | 5.3K | 119.6K |
| Burke Willaim PEVP, Chief Financial Officer · 21 transactions | — | 15.3Kas of Nov 2017 | 27.2K | — | 13.2K |
| Ryding Neil Mr.EVP, Global Manufacturing · 5 transactions | — | 15.2Kas of Jun 2018 | — | — | 1.1K |
| Kelly Michael PPresident, Global Markets · 34 transactions | — | 13.8Kas of Nov 2013 | 80.4K | — | 74.0K |
| Helsel DaveEVP, Global Manufacturing · 13 transactions | — | 13.2Kas of Apr 2015 | 10.5K | 416 | — |
| Johnson Lloyd EmersonDirector · 5 transactions | — | 12.9Kas of Jul 2025 | 12.9K | — | — |
| Lawlor ThomasPresident, Patient Division · 2 transactions | — | 12.5Kas of Nov 2007 | 12.5K | — | 12.5K |
| Gordon MikaelPresident, Global Markets · 26 transactions | — | 12.4Kas of May 2012 | 54.4K | 685 | 48.7K |
| Galvin RoyEVP, Chief Commercial Officer · 12 transactions | — | 12.3K | 40.7K | — | — |
| Granville WilliamVP, Manufacturing · 1 transaction | — | 12.2Kas of May 2008 | — | 411 | — |
| Nutter BradChairman of the Board, Director · 25 transactions | — | 10.6Kas of Jul 2010 | 605.6K | — | 600.0K |
| Best Lawrence CDirector · 77 transactions | — | 10.0Kas of Jun 2014 | 61.2K | 200.0K | 253.2K |
| Black PaulDirector · 4 transactions | — | 9.0Kas of Jul 2013 | 5.3K | — | — |
| Sakai RyojiPresident, Japan · 2 transactions | — | 8.0Kas of Jun 2007 | 8.0K | — | 8.0K |
| Nighan Warren JRVP WW Q&R Affairs · 11 transactions | — | 7.6Kas of Jul 2013 | 15.6K | — | 11.8K |
| Bryant Diane MDirector · 3 transactions | — | 7.1Kas of Jul 2025 | 7.1K | — | — |
| Maunsell Farris MaryanneVP, Chief Accounting Officer · 10 transactions | — | 6.2K | 6.9K | — | — |
| Chan FrankEVP, Chief Operating Officer · 3 transactions | — | 5.4K | 33.2K | — | — |
| McDaniel KathleenEVP Global Human Resources · 4 transactions | — | 5.0Kas of Aug 2014 | 5.7K | — | 406 |
| Popovsky Mark AVP, Corporate Medical Director · 19 transactions | — | 4.9Kas of May 2008 | 41.8K | 1.5K | 41.0K |
| Goldstein DanVP, Corporate Controller · 75 transactions | — | 4.4Kas of Jun 2022 | 33.0K | — | 31.0K |
| Scanlan JacquelineSVP, Global Human Resources · 43 transactions | — | 4.2Kas of Jun 2021 | 34.9K | — | 36.5K |
| Still William RocheVP & Gen Mrg, Therapeutics Bus · 8 transactions | — | 4.2Kas of May 2007 | 20.0K | 2.9K | 20.0K |
| O'Shaughnessy JamesVP, General Counsel · 1 transaction | — | 3.8Kas of May 2008 | — | 440 | — |
| Brancazio Phillip JohnVP, Global Manufacturing · 6 transactions | — | 3.1Kas of May 2011 | 2.8K | 209 | — |
| Swenson StephenVP & General Mgr, Global Plasm · 4 transactions | — | 3.0Kas of May 2008 | 400 | 238 | 623 |
| Pare AnthonyVP & Gen Mgr, Services Busines · 5 transactions | — | 3.0Kas of Jun 2008 | 1.0K | 231 | 1.0K |
| Lopez Alicia RVP, Corporate Affairs · 65 transactions | — | 3.0Kas of Apr 2011 | 184.1K | 2.4K | 205.8K |
| Ryan Ronald JVP and CFO · 24 transactions | — | 2.1Kas of Nov 2006 | 206.2K | 331 | 206.2K |
| Beucler MarkVP & GMGlobal Distrib Chan Mng · 1 transaction | — | 2.0Kas of May 2008 | — | 422 | — |
| Bolorforosh SaidEVP, Chief Technology Officer · 6 transactions | — | 2.0Kas of Nov 2019 | 3.0K | — | 1.1K |
| Conneely JanVP & GM, Arryx, Inc. · 1 transaction | — | 1.0Kas of May 2008 | — | 304 | — |
| Eckert UlrichPresident, Europe & Latin Am · 12 transactions | — | 890as of Nov 2006 | 17.0K | 159 | 15.0K |
| Corlin RemiPresident, Asia · 9 transactions | — | 884as of Aug 2008 | 21.9K | — | 21.0K |
| Hattori KeikoPresident, Haemonetics Japan · 1 transaction | — | 716as of May 2008 | — | 126 | — |
| Ruxin Michael IVP Global Software Strategies · 1 transaction | — | 215as of Nov 2010 | — | 215 | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -3.48M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.